Harpoon Therapeutics Stock Revenue
Harpoon Therapeutics fundamentals help investors to digest information that contributes to Harpoon Therapeutics' financial success or failures. It also enables traders to predict the movement of Harpoon Stock. The fundamental analysis module provides a way to measure Harpoon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harpoon Therapeutics stock.
Harpoon |
Harpoon Therapeutics Company Revenue Analysis
Harpoon Therapeutics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Harpoon Therapeutics Revenue | 37.34 M |
Most of Harpoon Therapeutics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harpoon Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Harpoon Therapeutics reported 37.34 M of revenue. This is 99.51% lower than that of the Biotechnology sector and 94.97% lower than that of the Health Care industry. The revenue for all United States stocks is 99.6% higher than that of the company.
Harpoon Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harpoon Therapeutics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harpoon Therapeutics could also be used in its relative valuation, which is a method of valuing Harpoon Therapeutics by comparing valuation metrics of similar companies.Harpoon Therapeutics is currently under evaluation in revenue category among its peers.
Harpoon Fundamentals
| Return On Equity | -2.84 | |||
| Return On Asset | -0.36 | |||
| Profit Margin | (0.82) % | |||
| Operating Margin | (2.73) % | |||
| Current Valuation | 475.25 M | |||
| Shares Outstanding | 21.4 M | |||
| Shares Owned By Insiders | 0.34 % | |||
| Shares Owned By Institutions | 82.85 % | |||
| Number Of Shares Shorted | 1.16 M | |||
| Price To Earning | (5.61) X | |||
| Price To Book | 108.42 X | |||
| Price To Sales | 13.19 X | |||
| Revenue | 37.34 M | |||
| Gross Profit | (49.48 M) | |||
| EBITDA | (35.45 M) | |||
| Net Income | (30.5 M) | |||
| Cash And Equivalents | 90.15 M | |||
| Cash Per Share | 2.72 X | |||
| Total Debt | 16.01 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 1.62 X | |||
| Book Value Per Share | 1.10 X | |||
| Cash Flow From Operations | (69.38 M) | |||
| Short Ratio | 0.37 X | |||
| Earnings Per Share | (8.62) X | |||
| Target Price | 23.67 | |||
| Number Of Employees | 53 | |||
| Beta | 2.1 | |||
| Market Capitalization | 492.35 M | |||
| Total Asset | 73.73 M | |||
| Retained Earnings | (352.52 M) | |||
| Working Capital | 2.29 M | |||
| Current Asset | 119.62 M | |||
| Current Liabilities | 18.4 M | |||
| Z Score | 10.72 | |||
| Net Asset | 73.73 M |
Pair Trading with Harpoon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Harpoon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harpoon Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Procter Gamble could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Procter Gamble when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Procter Gamble - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Procter Gamble to buy it.
The correlation of Procter Gamble is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Procter Gamble moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Procter Gamble moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Procter Gamble can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |